Heart Diseases Clinical Trial
Official title:
Study to Evaluate the Optimal Dose of Remifentanil Required to Ensure Apnoea During Magnetic Resonance Imaging of the Heart Under General Anaesthesia
What is the optimal maintenance dose of remifentanil to ensure apnoea, during breath hold episodes in children having cardiac MR imaging with general anaesthesia?
The management of congenital heart disease depends upon accurate imaging of the heart to
define anatomical abnormalities. The use of magnetic resonance imaging has grown in response
to this need. Young children, however, are unable to cooperate sufficiently to allow the scan
to occur; this necessitates the use of general anaesthesia.
The optimal anaesthetic management of children in this situation is complex. Imaging of an
acceptable quality depends on a low (normal) heart rate which is relatively constant during
the scan and frequent breath holds to avoid respiratory artefacts. Children undergoing such
scans commonly have significant cardiac and non-cardiac disease. A technique, currently used
at Alder Hey Hospital, is to use intravenous agents to provide anaesthesia: commonly a
mixture of the intravenous anaesthetic propofol and the potent opiate remifentanil. The
patient's own ventilation is suppressed by the use of remifentanil which also reduces heart
rate and heart rate variability. Controlled ventilation is provided via a ventilator and
endotracheal tube. Adequate doses of remifentanil are required to ensure suppression of the
patient's ventilation whilst excess doses are avoided to reduce the risk of adverse effects
(primarily arterial hypotension) and ensure rapid recovery.
Remifentanil dose has been studied during surgery(3-6), however this is a unique indication
and optimal dosage has not been formally studied. In particular the absence of any
stimulation from surgery is likely to mean that substantially lower doses of remifentanil
will be required.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624412 -
Different Intensities of Continuous Aerobic Exercises in Cardiac Rehab Phase 2
|
N/A | |
| Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
| Recruiting |
NCT04561908 -
Transcatheter Microguidewire Drilling for Transseptal Left Atrial Access
|
N/A | |
| Active, not recruiting |
NCT06190743 -
Perception of Cardiovascular Risk
|
||
| Completed |
NCT04580095 -
Artificial Intelligence for Improved Echocardiography
|
N/A | |
| Completed |
NCT04562636 -
Evaluating a Messaging Campaign in the United States
|
N/A | |
| Recruiting |
NCT03277365 -
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
|
N/A | |
| Active, not recruiting |
NCT05553106 -
Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care
|
||
| Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
| Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
| Enrolling by invitation |
NCT03314818 -
Natural History of Carotid Plaque as Determined by 3D Ultrasound
|
N/A | |
| Withdrawn |
NCT03289104 -
Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
|
N/A | |
| Completed |
NCT02917213 -
Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
|
||
| Completed |
NCT02046902 -
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
|
||
| Completed |
NCT01909349 -
Web-based Aftercare Intervention for Cardiac Patients
|
N/A | |
| Completed |
NCT01944254 -
The Precision of Pulmonary Artery Cardiac Output-measurements in Spontaneously Breathing Patients
|
N/A | |
| Recruiting |
NCT01457586 -
Hemoderivative Imputable Complications in Initial Uncomplicated Heart Surgery
|
Phase 4 | |
| Recruiting |
NCT01541163 -
Heart and Ischemic STrOke Relationship studY
|
N/A | |
| Recruiting |
NCT01207167 -
Mediators of Atherosclerosis in South Asians Living in America
|
||
| Terminated |
NCT00968383 -
Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
|
N/A |